Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)

Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry